Wntless promotes bladder cancer growth and acts synergistically as a molecular target in combination with cisplatin

The Wnt signaling pathway is ubiquitously activated in bladder cancer and regulates tumor growth. WLS might be a target protein for novel therapies in combination with established chemotherapy regimens.